08/08/22 4:05 PMNasdaq : AUGX earningslow floatAugmedix Reports Second Quarter 2022 Financial ResultsAugmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended June 30, 2022. “This quarter, we continued to see good momentum and are pleased withRHEA-AIneutral
08/08/22 4:01 PMNasdaq : AUGX partnershiplow floatAugmedix Announces Expanded Partnership with Adventist HealthAugmedix , a leading provider of automated medical documentation solutions, announces an innovative, data-driven partnership with Adventist Health , a nonprofit integratedRHEA-AIvery positive
08/03/22 8:00 AMNasdaq : AUGX clinical triallow floatAugmedix - Trio Health - CIIC First of its Kind Real-World Patient Ecosystem - Standardizing Relevant Clinical Data at the Point of CareToday, Trio Health (Trio) and Augmedix (Nasdaq: AUGX), in partnership with the Consortium of Independent Immunology Clinics (CIIC), announced the launch of an innovative platform to automate, standardize, and structure clinical patient data, rightRHEA-AIvery positive
07/25/22 4:05 PMNasdaq : AUGX conferencesearningslow floatAugmedix to Report Second Quarter 2022 Financial Results on August 8, 2022Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the second quarter of 2022 on Monday, August 8, 2022, after market close. CompanyRHEA-AIneutral
05/26/22 4:05 PMNasdaq : AUGX conferenceslow floatAugmedix to Present at the William Blair 42nd Annual Growth Stock ConferenceAugmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming William Blair Growth Stock Conference in Chicago. Augmedix’s management isRHEA-AIneutral
05/09/22 4:01 PMNasdaq : AUGX earningslow floatAugmedix Reports First Quarter 2022 Financial ResultsAugmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended March 31, 2022. Manny Krakaris, Chief Executive Officer of Augmedix, commented, “WeRHEA-AIneutral
04/25/22 4:05 PMNasdaq : AUGX conferencesearningslow floatAugmedix to Report First Quarter 2022 Financial Results on May 9, 2022Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the first quarter of 2022 on Monday, May 9, 2022, after market close. Company managementRHEA-AIneutral
03/29/22 4:05 PMNasdaq : AUGX conferenceslow floatAugmedix to Participate at the 2022 Lytham Partners Spring Investor ConferenceAugmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Investors Conference, which will take place virtually fromRHEA-AIneutral
03/29/22 8:00 AMNasdaq : AUGX managementlow floatAugmedix Names William Febbo as New Member to its Board of DirectorsAugmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced that William Febbo, Chief ExecutiveRHEA-AIvery positive
03/21/22 4:05 PMNasdaq : AUGX earningslow floatAugmedix Reports Fourth Quarter and Full Year 2021 Financial Results Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended December 31, 2021. “We are pleased with the progress we made in 2021, as weRHEA-AIneutral